StonvexLoading…
StonvexStonvexStonvexCore line items from PLXS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 2026-04-04 | Q1 2026 2026-01-03 | Annual 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $2.23M | $1.07M | $4.03B | $2.97M |
Operating Income | $116.30M | $54.46M | $202.37M | $149.26M |
Net Income | $90.99M | $41.18M | $172.88M | $121.46M |
EPS (Diluted) | $3.32 | $1.51 | $6.26 | $4.39 |
Total Assets | $3.36B | $3.19B | $3.14B | $3.11B |
Total Liabilities | $1.87B | $1.70B | $1.68B | $1.69B |
Cash & Equivalents | $303.13M | $248.82M | $306.46M | $237.57M |
Free Cash Flow OCF − CapEx | $-34.57M | $-50.58M | $153.97M | $56.77M |
Shares Outstanding | 26.76M | 26.71M | 26.83M | 26.98M |